Dermata Therapeutics (DRMA) Q2 2024 Earnings

15MayConfirmed
Q1 2023
Q3 2023
Q4 2023
Q2 2024
-5.4
-3.6
-1.8
0

Details

Expected EPS
-5.4
Actual EPS
-0.47
Surprise EPS
4.93
Surprise Percent
+91.3%

Description

Dermata Therapeutics (DRMA) has reported earnings of -0.47 per share for Q2 2024.

0 Comments

Share your thoughts